Skip to main content

Month: September 2020

RECORDATI: LICENZA PER SPRAY NASALE INNOVATIVO A BASE DI EPINEFRINA PER LA PREVENZIONE DELL’ANAFILASSI

RECORDATI: LICENZA PER SPRAY NASALE INNOVATIVO A BASE DI EPINEFRINA PER LA PREVENZIONE DELL’ANAFILASSIMilano, 21 settembre 2020 – Recordati annuncia la firma di un accordo esclusivo di licenza con ARS Pharmaceuticals, una società farmaceutica privata basata negli Stati Uniti d’America, per la commercializzazione nell’Unione Europea, Islanda, Liechtenstein, Norvegia, Svizzera, Regno Unito, Russia/CIS, Turchia, Medio Oriente a i paesi africani francofoni, di ARS-1, uno spray nasale a base di epinefrina, in fase avanzata di sviluppo per il trattamento in emergenza di reazioni allergiche gravi che potrebbero portare all’anafilassi. Le condizioni dell’accordo prevedono che sia dovuto un pagamento up-front alla firma del contratto oltre al pagamento di milestones futuri associati al processo regolatorio e traguardi commerciali.L’anafilassi...

Continue reading

Provectus Biopharmceuticals Highlights Stage IV M1d Patient Outcome from Combination Therapy Trial of PV-10® and KEYTRUDA® for Checkpoint-Refractory Advanced Cutaneous Melanoma at ESMO Virtual Congress 2020

Complete response of all injected lesionsRegression of non-injected inguinal node, lung, and brain metastasesExpanded data set of trial subject providedKNOXVILLE, TN, Sept. 21, 2020 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today highlighted the clinical outcome of a Stage IV M1d patient (Subject 0602) in the Company’s Phase 1b/2 study of small molecule autolytic cancer immunotherapy PV-10, an injectable formulation of Provectus’ proprietary rose bengal disodium (RBD), in combination with KEYTRUDA (pembrolizumab) for the treatment of advanced cutaneous melanoma in patients refractory to immune checkpoint blockade (CB). Preliminary response, safety, and immune correlative data from this CB-Refractory Cohort were previously presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, held online from...

Continue reading

Kentucky First Federal Bancorp Releases Fiscal Year Results

HAZARD, Ky. and FRANKFORT, Ky. and DANVILLE, Ky. and LANCASTER, Ky., Sept. 21, 2020 (GLOBE NEWSWIRE) — Kentucky First Federal Bancorp (Nasdaq: KFFB), (the “Company”) the holding company for First Federal Savings and Loan Association of Hazard and First Federal Savings Bank of Kentucky, announced that a non-cash $13.6 million goodwill impairment charge led to a reported loss of $13.3 million or $1.61 per common share for the quarter ended June 30, 2020. This compares to net income of $300,000 or $0.04 per common share for the quarter ended June 30, 2019. The Company reported a net loss of $12.5 million or $1.52 per common share for the twelve months ended June 30, 2020, compared to net earnings of $812,000 or $0.10 per common share for the twelve months ended June 30, 2019.The Company recorded a goodwill impairment charge, which...

Continue reading

Centerra Gold 2020 Third Quarter Results Conference Call and Webcast

TORONTO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Centerra Gold Inc. (TSX: CG) will host a conference call and webcast of its 2020 third quarter financial and operating results at 9:00AM Eastern time on Wednesday November 4, 2020. The results are scheduled to be released before the market opens on Wednesday, November 4, 2020.North American participants may access the call toll-free at +1 (800)-935-9319.International participants may access the call at +1 (416)-981-9009.The conference call is being webcast by Intrado and can be accessed live at Centerra Gold’s website at www.centerragold.com. Presentation slides of the third quarter results will also be accessible on Centerra Gold’s website at www.centerragold.comAn audio recording of the call will be available approximately two hours after the call via telephone until midnight Eastern...

Continue reading

L.B. Foster Company to Host Investor Call Regarding the Sale of IOS Test & Inspection Services Business

PITTSBURGH, Sept. 21, 2020 (GLOBE NEWSWIRE) — L.B. Foster Company (NASDAQ: FSTR), today announced that it will host a conference call to discuss the sale of the IOS Test & Inspection Services Business on Monday, September 28, 2020 at 4:00 p.m. Eastern Time.  A brief presentation will be available on the Company’s website under the Investor Relations page immediately before the conference call begins.Those wishing to participate via the telephone may dial in at (833) 614-1392 (U.S. & Canada) or (914) 987-7113 (International).  Those wishing to participate via the webcast should access the call through L.B. Foster’s Investor Relations page of the company’s website (www.lbfoster.com).A conference call replay will be available through October 5, 2020.  To access the replay, please dial (855) 859-2056 (U.S. & Canada) or...

Continue reading

BWR Exploration Inc. Closes Second and Final Tranche of Private Placement

TORONTO, Sept. 21, 2020 (GLOBE NEWSWIRE) — BWR Exploration Inc. (TSX.V: BWR) (“BWR” or the “Company”) is pleased to announce the closing of the second and final tranche (the “Closing”) of the previously announced non-brokered private placement (the “Offering”) for aggregate gross proceeds of $140,000, on September 18, 2020, through the purchase of 2,800,000 Units consisting of 2,800,000 common shares (“Common Shares”) plus 1,400,000 warrants, issued in connection with the Closing.As previously announced, each Unit consists of 1 Common Share, plus one half of one common share purchase warrant (a “Warrant”) of the Company. Each Full Warrant will expire 36 months from the date of issue (the “Full Warrant Expiry Date”) and will entitle the holder thereof to purchase one Common Share (a “Full Warrant Share”) at a price of $0.075 per...

Continue reading

Reyna Silver Welcomes Peter Jones as Chairman and Announces Additional Changes to the Board of Directors

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES.VANCOUVER, British Columbia and HONG KONG, Sept. 21, 2020 (GLOBE NEWSWIRE) — Reyna Silver Corp. (“Reyna” or the “Company”) (TSXV: RSLV) announces the following changes to the Company’s Board of Directors (the “Board”):(i)      Peter Jones (a director) has been appointed as the Chairman;(ii)      Sandy Chim has stepped down as Chairman and director to become the Chairman of the Advisory Board; and(iii)     Evaristo Trevino has been appointed as a new member of the Board.Mr. Jones was instrumental in the development and transformation of HudBay Minerals Inc. (“HudBay”) and its predecessor, Hudson Bay Mining and Smelting Company, Ltd. (“HBMS”). As the CEO of HudBay, in 2004 he orchestrated the company’s initial public...

Continue reading

Agent Information Software (AIFS) Publishes 2020 Second Quarter Financials

RANCHO CUCAMONGA, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — The parent company of Auto-Graphics, Inc., Agent Information Software released their earnings for the second quarter of 2020, ending June 30, 2020. Auto-Graphics, Inc., is an industry-leading provider of library automation software. A-G was the first to provide Cloud-based library resource sharing solutions.  AIFS continues to strengthen its financial position as the COVID-19 pandemic continues to sweep the country. AIFS reported a net income of $158k with an EBITDA of $528k that represented 20.3% of sales at quarter end. The company issued a dividend of $0.03 per share on June 12th. Cash flow remained strong into the second quarter with no drop in customer receipts and an increased focus on costs. AIFS reported EPS of $0.04 on weighted average shares outstanding of 4,474,577.The...

Continue reading

ADLPartner : Déclaration des transactions sur actions propres réalisées du 14 au 18 septembre 2020

ADLPartnerSociété anonyme à directoire et conseil de surveillance au capital de 6 478 836 euros3, avenue de Chartres 60500 – CHANTILLY393 376 801 R.C.S. CompiègneDéclaration des transactions sur actions propres réalisées du 14 au 18 septembre 2020Présentation agrégée par jour et par marchéDétail transaction par transactionRelations Investisseurs & Informations financièresTel : +33 1 41 58 72 03 – Courriel : relations.investisseurs@adlpartner.frADLPartner est cotée sur Euronext Paris – Compartiment CCodes ISIN : FR0000062978-ALP – Bloomberg : ALP FP – Reuters : ALDP.PAwww.adlpartner.comPièce jointeADLPartner_rachats_actions_21092020

Continue reading

NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology

WOBURN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation.”The patent covers core Quell technology that regulates electrical stimulation based on the device orientation.  No other wearable pain relief device has position dependent stimulation control technology that allows the device to automatically modulate treatment based on the user’s body position. This technology is used in Quell’s overnight therapy modes as well for other features.“We are pleased to have received this latest patent, which describes core Quell technology,” said Shai N. Gozani, M.D., Ph.D., President...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.